SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/28/13 -- VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology…
Continue ReadingTag: vistagen-therapeutics
UPDATE: VistaGen Announces $36 Million Strategic Financing Agreement
Proceeds Will Accelerate Stem Cell Technology-Based Drug Rescue, Predictive Toxicology and Drug Metabolism Programs
Continue ReadingVistaGen Announces $36 Million Strategic Financing Agreement
Proceeds Will Accelerate Stem Cell Technology-Based Drug Rescue, Predictive Toxicology and Drug Metabolism Programs
Continue ReadingVistaGen Therapeutics Announces Strategic Financing With Platinum Long Term Growth Fund
Company Also Completes Long-Term Debt Restructuring
Continue Reading